Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Endothelial Function in Diabetes and Glaucoma
NCT00913562Phase 4Withdrawn
- Sponsor
- Medical University of Vienna
- Start
- Jun 2009
- Primary completion
- Nov 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in diabetes mellitus (DM), Glaucoma, sponsored by Medical University of Vienna. Planned start Jun 2009; status: withdrawn.
02
Drugs
rosuvastatin
03
Conditions
diabetes mellitus (DM)Glaucoma
Beyond the preview
Go deeper on NCT00913562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00913562.